Latest / Vertical SaaS with Fexingo: Industry-Specific Software for Healthcare, Construction, Legal / How Vertical SaaS Is Winning Over Independent Pharmacies
Transcript
- Lucas: So we talk a lot about vertical SaaS taking over industries like construction, legal, dental. But there's one market that's been quietly getting gutted for years, and a handful of software companies are trying to reverse it. Luna: Independent pharmacies. Lucas: Exactly. You've got about 22,000 independent community pharmacies left in the U.S. — down from over 40,000 twenty years ago. They're closing at roughly a thousand a year, squeezed by pharmacy benefit managers, by chains like CVS and Walgreens, by mail-order prescription services. Luna: And until recently, the software they were using was basically a digital version of what they had in the 1990s. Clunky, on-premise, no integration. Lucas: Right. Legacy systems like QS/1 or PDX — they handle the basics, but they weren't built for the modern workflow. A pharmacist today has to verify insurance in real time, process prior authorizations, manage inventory across hundreds of drugs, send refill reminders, offer immunizations, maybe do telehealth. That's a lot for a system designed when fax machines were cutting-edge. Luna: So a new generation of vertical SaaS providers stepped in. I'm thinking of PioneerRx, WinRx, Liberty Software — companies that rebuilt the pharmacy management system from scratch in the cloud. Lucas: PioneerRx is probably the most interesting case. Founded in 2009, based in Shreveport, Louisiana. They now have over 4,000 pharmacy locations on their platform. They're not public, but they're growing fast because they solved a specific pain point: the workflow itself. Luna: What do they do differently? Lucas: So the old systems are transactional — you type in the prescription, you fill it, you print the label. PioneerRx is workflow-oriented. It scans the prescription, checks for drug interactions, submits the claim to the PBM, alerts the pharmacist if there's a cheaper alternative, and then — after the patient leaves — it auto-generates adherence reports and sends refill reminders. Luna: That's a huge time saver. Especially for an independent pharmacy that might only have one or two pharmacists on staff. Lucas: And time is money in a very literal sense. Independent pharmacies operate on razor-thin margins — typically around 2 to 3 percent net profit. The average pharmacy fills maybe 200 to 300 prescriptions a day. Every minute saved per prescription compounds. Luna: I've read that PioneerRx claims to reduce administrative time by up to 40 percent. Is that realistic? Lucas: I spoke with a pharmacist in Ohio who runs three locations — he said after switching from QS/1 to PioneerRx, he was able to reallocate about 15 hours per week per store from paperwork to patient care. That's significant because the real revenue opportunity for independents isn't the prescription margin — it's clinical services. Luna: Right — immunizations, health screenings, medication therapy management. Those pay better and build customer loyalty. Lucas: And the software can actually enable that. PioneerRx has a module for scheduling and billing immunizations, it integrates with state immunization registries, it tracks which patients are due for a flu shot. That's the kind of thing a legacy system just didn't do. Luna: But let's talk about the elephant in the room — the PBMs. Pharmacy benefit managers like Express Scripts, CVS Caremark, OptumRx. They control the pricing, the reimbursement rates, the network access. Can software really help an independent pharmacy fight that? Lucas: It doesn't solve the fundamental power imbalance. But it can help on the margins — literally. One feature that's become popular is real-time benefit verification. The pharmacist runs the claim, the system immediately shows what the PBM will reimburse, and if it's below cost, the pharmacist can decide whether to fill it or counsel the patient on an alternative. Luna: That's a big deal because in the old system, you wouldn't know your reimbursement until after you filled the prescription. You could be losing money on every pill. Lucas: Exactly. And there's another angle — some of these vertical SaaS companies are building analytics tools that help pharmacies understand their payer mix. Which PBMs are paying well, which are paying poorly, and where you can negotiate. Luna: But here's the thing — the PBMs are getting into the software game too. CVS has its own pharmacy management system. Optum owns a big chunk of the EHR market. Isn't there a risk that the vertical SaaS players get crushed by the very companies they're trying to help pharmacies compete against? Lucas: It's a real threat. The PBMs have scale, they have data, they have relationships with the insurers. But the counterargument is that independent pharmacies don't trust pbm owned software. They want a vendor whose incentives are aligned with theirs. Luna: So independence as a feature. Lucas: Right. And that's a powerful narrative. Look, this episode is for operators and builders, people who are trying to run a business or build one. If these conversations help you think about your own industry differently, then honestly, if today was worth a coffee to you, that's the link — buy me a coffee dot com slash fexingo. No pressure, just a way to keep this ad-free. Luna: And we mean it — just the smallest acknowledgment. It matters more than you'd think. Lucas: Okay, so back to the competitive landscape. There's another company called WinRx, which is owned by the pharmacy buying group McKesson — but it's still a separate unit, and they've been adding features like automated prior authorization and medication synchronization. Luna: Med sync — that's where the pharmacy fills all of a patient's monthly prescriptions on the same day, so they only have to make one trip. Lucas: Exactly. It sounds simple, but it's been shown to improve adherence by 15 to 20 percent. And for the pharmacy, it means more predictable workflow and better cash flow. WinRx has baked that into their platform as a standard feature. Luna: So what's the business model for these vertical SaaS companies? Subscription per location per month? Lucas: Typically $500 to $1,500 per month per pharmacy, depending on the modules. Some also take a small per-claim transaction fee. The total addressable market is about 22,000 independent pharmacies, but you also have another 15,000 or so small chain pharmacies with two to five locations. Luna: That's a pretty small TAM compared to, say, restaurant or construction software. Lucas: It is. But the switching costs are high. Once a pharmacy is on a system, all their prescription data, patient history, insurance contracts — they're locked in. Churn is very low. And there's an ongoing need for updates as regulations change. That's why private equity has been circling. Luna: Any notable acquisitions? Lucas: In 2021, Francisco Partners acquired a majority stake in PioneerRx. They also own a bunch of other healthcare IT companies, so there's potential for cross-sell. And in 2019, the pharmacy software company ComputerRx was bought by a PE firm. So yes, there's deal activity, but it's not a hot market like AI. Luna: What about the telehealth angle? COVID accelerated a lot of that. Lucas: Big time. Many states relaxed rules around pharmacist-provided telehealth. Some of these platforms now include video consultation modules, e-prescribing for controlled substances, and integration with third-party telehealth platforms. The pharmacist in Ohio I mentioned — he said his pharmacy started doing 30 to 40 telehealth consultations a week during the pandemic, and about half of those turned into new patients. Luna: So the software becomes a patient acquisition tool as well. Lucas: Exactly. And that's the broader lesson for vertical SaaS — when you deeply understand the workflow, you can identify adjacent revenue streams that the customer didn't even know they had. The pharmacy didn't think of itself as a telehealth provider, but the software made it possible. Luna: I want to push back a little. All this sounds great, but the pharmacy is still at the mercy of the PBM. One change to the reimbursement formula can wipe out months of efficiency gains. Lucas: That's fair. And some observers argue that vertical SaaS for pharmacies is a Band-Aid on a broken system. The real solution would be regulatory reform — like the Pharmacy Benefit Manager Transparency Act that's been kicking around Congress. But software is what operators can control today. Luna: And if it helps independents survive another year, that's meaningful. There's a reason people trust their local pharmacist more than the big box. Lucas: Totally. And the data backs that up — independent pharmacies consistently score higher on patient satisfaction surveys. The challenge is translating that trust into profitability. Software can't fix everything, but it can make the math a little less brutal. Luna: So if you're a builder looking at vertical SaaS, what's the lesson from pharmacy? Lucas: Look for an industry where the core workflow is still analog or running on ancient software, where the customer base is under financial pressure, and where there's a clear path to adding value beyond just processing transactions. Pharmacy checks all those boxes. Luna: And maybe avoid industries where your biggest potential customer is also your biggest competitor. Lucas: Ha, right. That's the PBM problem. But that's also what makes it interesting — the vertical SaaS company has to be a genuine ally, not just a vendor. Luna: Alright, well I'm going to go look up my local independent pharmacy and ask what software they use. Lucas: Let us know what they say. That's it for this episode of Vertical SaaS with Fexingo.